78
61
Growth Score 78 in past quarter
-9 pts
Heat Score 61 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
195641
Sandoz is a supplier of off-patent medicines.
- Anne Marie de Jonge Schuermans: Global Head Supply OperationsPast Role: Biogen, Vice President Global Supply Chain Ops & Strategic Partnerships
- Glenn Gerecke: Global Head of Technical OperationsPast Role: Phlow, Chief Operating Officer
About the Company
Sandoz is a pharmaceutical company that develops, supplies, and markets pharmaceuticals, prescription drugs, biosimilars, generic antibiotics, dermatology, and transplantation products. It is a generic cardiovascular therapeutics, central nervous system therapeutics, pain relievers, and eye care products, as well as oncology, respiratory and
hormone therapeutics, and off-patent medicines.